$0.05 EPS Expected for Wright Medical Group N.V. (WMGI)

January 18, 2018 - By Darrin Black

 $0.05 EPS Expected for Wright Medical Group N.V. (WMGI)

Analysts expect Wright Medical Group N.V. (NASDAQ:WMGI) to report $0.05 EPS on February, 20.They anticipate $0.11 EPS change or 183.33 % from last quarter’s $-0.06 EPS. WMGI’s profit would be $5.22M giving it 113.50 P/E if the $0.05 EPS is correct. After having $-0.16 EPS previously, Wright Medical Group N.V.’s analysts see -131.25 % EPS growth. The stock decreased 2.74% or $0.64 during the last trading session, reaching $22.7. About 1.26 million shares traded or 32.07% up from the average. Wright Medical Group N.V. (NASDAQ:WMGI) has risen 49.62% since January 18, 2017 and is uptrending. It has outperformed by 32.92% the S&P500.

Wright Medical Group N.V. (NASDAQ:WMGI) Ratings Coverage

Among 18 analysts covering Wright Medical Group (NASDAQ:WMGI), 14 have Buy rating, 0 Sell and 4 Hold. Therefore 78% are positive. Wright Medical Group had 36 analyst reports since August 20, 2015 according to SRatingsIntel. The firm has “Buy” rating by UBS given on Tuesday, September 22. The firm has “Hold” rating given on Thursday, August 3 by Oppenheimer. The firm earned “Buy” rating on Thursday, September 3 by Brean Capital. The firm has “Buy” rating given on Wednesday, November 4 by Sterne Agee CRT. Jefferies upgraded the shares of WMGI in report on Monday, November 30 to “Buy” rating. Leerink Swann maintained the stock with “Outperform” rating in Thursday, September 3 report. The firm earned “Neutral” rating on Tuesday, April 11 by Bank of America. The stock of Wright Medical Group N.V. (NASDAQ:WMGI) earned “Buy” rating by RBC Capital Markets on Friday, September 1. The firm earned “Outperform” rating on Sunday, September 6 by William Blair. The stock has “Buy” rating by Jefferies on Thursday, June 29.

Wright Medical Group N.V., a medical device company, designs, makes, markets, and sells extremities and biologics products.in the United States, Europe, the Middle East, Africa, and internationally. The company has market cap of $2.37 billion. The firm offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth. It currently has negative earnings. It also provides sports medicines and other products to mechanically repair tissue-to-tissue or tissue-to-bone injuries.

More notable recent Wright Medical Group N.V. (NASDAQ:WMGI) news were published by: Marketwatch.com which released: “Wright Medical Group NV” on December 22, 2009, also Nasdaq.com with their article: “5 Reasons Why You Should Offload Wright Medical Stock Now” published on January 17, 2018, Globenewswire.com published: “Wright Medical Group NV Announces Acquisition of IMASCAP SAS” on December 14, 2017. More interesting news about Wright Medical Group N.V. (NASDAQ:WMGI) were released by: Globenewswire.com and their article: “Wright Medical and Tornier Complete Merger and Create Premier High-Growth …” published on October 01, 2015 as well as Bizjournals.com‘s news article titled: “Wright Medical reports net loss, optimism for year ahead” with publication date: May 04, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.